Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer

NCT00075738 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: cisplatin
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group